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PRACTICAL PEARL: HEMOGLOBIN ABNORMALITIES ON NEWBORN SCREEN 
 
Introduction  Newborn screening (NBS) for hemoglobinopathies allows 
identification of children with hemoglobin abnormalities associated 
with disease and initiation of referral and treatment.  
 A detailed review of the NBS program for hemoglobinopathies is 
available on the New England Pediatric Sickle Cell Consortium 
website: https://nepscc.org/health-providers/screening/ 
Initial Evaluation and 
Management by 
Primary Care  
 NBS results are reported for hemoglobins in order of relative 
abundance, e.g., “FA” indicates abundance of hemoglobin F is 
greater than A (normal finding). 
 Hemoglobinopathies are identified when hemoglobins other than F 
and A are present. In sickle cell anemia, the relative abundance is 
important in determining trait versus disease. Sickle cell trait would 
demonstrate an FAS pattern; sickle cell disease demonstrates an FS 
pattern.  
 If patterns consistent with sickle cell disease (FS, FSA, FSC, FSV) are 
reported, the child should immediately be treated with prophylactic 
penicillin (125mg po BID) and referred to Pediatric Hematology. 
 Bart’s hemoglobin, reported as FAB, reflects some degree of alpha-
thalassemia; follow up is determined by family history and the 
frequency of the condition in certain ethnic groups.  
When to Refer  Hemoglobin patterns consistent with a form of sickle cell disease 
(FS, FSA, FSC, FSV). 
How to Refer  (413) 794-KIDS  
 Questions for the hematologist: (413) 794-9338 
What to Expect From 
Baystate Children’s 
Hospital Visit 
 Confirmatory testing, consultation, treatment and follow-up care 
based on the diagnosis.  
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